FDA NDC Directory · JSON-LD · Markdown

Sildenafil Citrate

NDC 70710-1716 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215708
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsSILDENAFIL CITRATE (10 mg/mL)
Marketing started20221027
Package count2

External sources

Source: openFDA. Public-domain (CC0).